News | November 06, 2023
Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
This product will be manufactured at Lupin's Nagpur facility in India
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
